Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Cahill

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Cancer Discovery|February 28, 2024
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector PopulationAnthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, et al.
Blood Advances|February 7, 2019
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Journal of Neurosurgery|October 9, 2020
Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgeryAmar S Shah, Peter T Sylvester, Alexander T Yahanda, et al.
Oncotarget|January 10, 2018
Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.
Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.
Neurosurgery|August 18, 2020
Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter StudyAmar S Shah, Alexander T Yahanda, Peter T Sylvester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Cancer Discovery|February 28, 2024
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector PopulationAnthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, et al.
Blood Advances|February 7, 2019
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Journal of Neurosurgery|October 9, 2020
Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgeryAmar S Shah, Peter T Sylvester, Alexander T Yahanda, et al.
Oncotarget|January 10, 2018
Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.
Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.
Neurosurgery|August 18, 2020
Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter StudyAmar S Shah, Alexander T Yahanda, Peter T Sylvester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Pageof 20